Remdesivir(Veklury) |
appearance as argument number 1 |
(documentation Remdesivir EnglishLanguage "Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Some studies found antiviral activity against several RNAViruses including SARS Coronavirus and MERS Coronavirus, but it is not approved by the USFoodAndDrugAdministration for any indication. [in part from Wikipedia]") | VirusProteinAndCellPart.kif 1273-1278 | |
(medicine Remdesivir Covid19) | VirusProteinAndCellPart.kif 1271-1271 | Veklury is medicine for Covid |
(roomTempState Remdesivir Liquid) | Mid-level-ontology.kif 31909-31909 | roomTempState Veklury and liquid |
(subclass Remdesivir AntiViralMedicine) | VirusProteinAndCellPart.kif 1268-1268 | Veklury is a subclass of anti viral medicine |
appearance as argument number 2 |
(termFormat EnglishLanguage Remdesivir "Remdesivir") | VirusProteinAndCellPart.kif 1269-1269 | |
(termFormat EnglishLanguage Remdesivir "Veklury") | VirusProteinAndCellPart.kif 1270-1270 |